Tenet Healthcare (NYSE: THC) Earnings Q3 2010




View Tenet Healthcare's (NYSE: THC) Q3 Earnings Report


Highlights:

  • Net income  of $932 million compared to $3 million net loss in Q3 2009
  • Earnings of $1.68 per diluted share compared to a loss of $0.01 per diluted share in Q3 2009
  • Deferred tax benefit of $981 million recognized, $1.75 per diluted share
  • Early extinguishment of debt loss of $55 million, or $0.06 per diluted share
  • Outlook for 2010 net income from continuing operations increased to $110 million-$140 million
  • In October, $46 million in medical office building sales proceeds received
  • California provider fee plan receives partial CMS approval in October
  • $64 million in net revenue expected for Q4
  • $800 million new bank credit line completed

Check out Tenet Healthcare's current earnings estimates from CNN Money

See how THC is performing right now

Tenet's website: www.tenethealth.com

Suggested Articles

Express Scripts saved its plan sponsors $4.3 billion last year through its slate of SafeGuardRx value-based care programs.

The COVID-19 pandemic is widening disparities in medication adherence between patient populations, which could have major health implications.

Hospitals across the U.S. saw margin declines in February, a new report from Kaufman Hall found.